Sugammadex Labatec 200 mg/2ml, solution injectable
7680692390011
CH-69239
Injektionslösung
Associated product:
SUGAMMADEX Labatec sol inj 200 mg/2ml 10 pce
1 / 3
google
Article details
- Package size
- 10
- Selling units
- 10
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
217.6 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
18.9 MG | Substance | HBESI |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 69239
- Drug name
- Sugammadex Labatec, solution injectable
- Galenic form
- LSINJ
- ATC Code
- V03AB35
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 29/09/2023
- Authorization expiration date
- 28/09/2028
- IT Number
- 15.01.0.
- Domain
- Human medicine
Package details
- Description (FR)
- SUGAMMADEX Labatec sol inj 200 mg/2ml 10 pce
- Description (DE)
- SUGAMMADEX Labatec Inj Lös 200 mg/2ml 10 Stk
- Market launch
- 29/09/2023
- Narcotic (BTM)
- No
Other package sizes (1)
SUGAMMADEX Labatec sol inj 500 mg/5ml 10 pce
10 DUR
GTIN: 7680692390028